Showing results (31-40 of 270) with videos related to
Sort By:
Pageof 27
Biochemical and Biophysical Research Communications|August 30, 1985
Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell lineJ Filmus, M N Pollak, J G Cairncross, et al.Cancer Research|September 15, 2000
Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapyC L Nutt, M Noble, A F Chambers, et al.Journal of Neuro-Oncology|April 16, 1998
Bihemispheric malignant glioma: one size does not fit allG S Bauman, B J Fisher, J G Cairncross, et al.Current Opinion in Neurology|November 28, 2001
Oligodendrogliomas: clinical and genetic correlationsJ R PerryNeurosurgical Focus|December 13, 2006
Bias, benefit, or both: evaluating new glioma therapiesJ R PerryJournal of the National Cancer Institute|October 17, 1998
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomasJ G Cairncross, K Ueki, M C Zlatescu, et al.Neurology|May 1, 1988
Steroid-induced CT changes in patients with recurrent malignant gliomaJ G Cairncross, D R Macdonald, J H Pexman, et al.Journal of Neurosurgery|October 1, 1996
Salvage chemotherapy for oligodendrogliomaK Peterson, N Paleologos, P Forsyth, et al.Journal of Neuro-Oncology|August 1, 1991
Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expressionA F Chambers, G H Denhardt, S M Wilson, et al.Neurology|September 25, 1999
Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendrogliomaN A Paleologos, D R Macdonald, N A Vick, et al.Pageof 27